上皮性卵巢癌-话题@MedSci

#上皮性卵巢癌#

21篇内容 | 2095人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2173248, encodeId=4afa21e324805, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a> <a href='/topic/show?id=655b31640c7' target=_blank style='color:#2F92EE;'>#分子特征#</a> <a href='/topic/show?id=a78b1082e0b5' target=_blank style='color:#2F92EE;'>#组织学亚型#</a>, objectTitle=吴琪俊/宁尚伟团队《自然·通讯》：基于蛋白质组学特征解析上皮性卵巢癌不同组织学亚型的分子特征和治疗靶点, objectType=article, longId=803612, objectId=ed6b803612fa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, objectUrl=/article/show_article.do?id=ed6b803612fa, replyNumber=0, likeNumber=92, createdTime=2023-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ed6b803612fa, moduleTitle=吴琪俊/宁尚伟团队《自然·通讯》：基于蛋白质组学特征解析上皮性卵巢癌不同组织学亚型的分子特征和治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed6b803612fa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2148955, encodeId=48de21489556c, content= <a href='/topic/show?id=4a9e66832e7' target=_blank style='color:#2F92EE;'>#激素替代治疗#</a>（menopausal hormone therapy，MHT）是缓解绝经后患者<a href='/topic/show?id=28326026907' target=_blank style='color:#2F92EE;'>#更年期#</a>症状的有效疗法，妇科恶性肿瘤术后患者使用MHT的安全性和有效性是临床上持续关注的重点问题。早期<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>（endometrial cancer，EC）术后行MHT不增加复发风险，且有利于提高生活质量。<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>（ovarian cancer，OC）患者术后MHT对无病生存期和总生存期无不利影响，但不建议用于<a href='/topic/show?id=ee76106452cb' target=_blank style='color:#2F92EE;'>#卵巢性索间质肿瘤#</a>等<a href='/topic/show?id=d7b210645382' target=_blank style='color:#2F92EE;'>#非上皮性卵巢肿瘤#</a>。但是激素替换治疗的风险仍然不容忽视，尤其是早筛不严格的前提下。, objectTitle=【综述】| 妇科恶性肿瘤术后激素替代治疗的研究进展, objectType=article, longId=782585, objectId=a1d6e825850f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230720/1689788891709_5579292.jpg, objectUrl=/article/show_article.do?id=a1d6e825850f, replyNumber=0, likeNumber=119, createdTime=2023-07-20, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=a1d6e825850f, moduleTitle=【综述】| 妇科恶性肿瘤术后激素替代治疗的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1d6e825850f)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1653759, encodeId=e5f71653e59c3, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=上皮性卵巢癌PARP抑制剂相关生物标志物有哪些？重点归纳！, objectType=article, longId=218423, objectId=5081218423dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5081218423dc, replyNumber=0, likeNumber=80, createdTime=2022-01-16, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5081218423dc, moduleTitle=上皮性卵巢癌PARP抑制剂相关生物标志物有哪些？重点归纳！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5081218423dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653760, encodeId=f7731653e60bf, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=伊立替康联合奈达铂治疗复发耐药晚期上皮性卵巢癌的疗效研究, objectType=article, longId=220686, objectId=a17d220686e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a17d220686e6, replyNumber=0, likeNumber=72, createdTime=2021-12-30, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a17d220686e6, moduleTitle=伊立替康联合奈达铂治疗复发耐药晚期上皮性卵巢癌的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a17d220686e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653753, encodeId=52901653e53aa, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌, objectType=article, longId=204982, objectId=3e1720498269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e1720498269, replyNumber=0, likeNumber=83, createdTime=2021-09-07, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e1720498269, moduleTitle=欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e1720498269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653758, encodeId=9f121653e58cf, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果, objectType=article, longId=213341, objectId=9b0321334101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0321334101, replyNumber=0, likeNumber=73, createdTime=2022-05-09, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0321334101, moduleTitle=Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0321334101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653755, encodeId=5a161653e555a, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理, objectType=article, longId=206089, objectId=567b2060892a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=567b2060892a, replyNumber=0, likeNumber=82, createdTime=2021-06-13, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=567b2060892a, moduleTitle=指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=567b2060892a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653754, encodeId=4f391653e5498, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局, objectType=article, longId=206075, objectId=3de22060e54b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3de22060e54b, replyNumber=0, likeNumber=93, createdTime=2021-09-16, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3de22060e54b, moduleTitle=上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3de22060e54b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653757, encodeId=99031653e5753, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理, objectType=article, longId=206531, objectId=7bc9206531c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bc9206531c8, replyNumber=0, likeNumber=121, createdTime=2021-07-01, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bc9206531c8, moduleTitle=上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bc9206531c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653756, encodeId=a8561653e56de, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=有此一说：不成功妊娠，或可降低浸润性上皮性卵巢癌风险, objectType=article, longId=206092, objectId=7ebf206092c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ebf206092c8, replyNumber=0, likeNumber=86, createdTime=2021-08-14, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ebf206092c8, moduleTitle=有此一说：不成功妊娠，或可降低浸润性上皮性卵巢癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ebf206092c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653751, encodeId=4b701653e5114, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Clinica Chimica Acta：对晚期上皮性卵巢癌或腹膜癌间隔减容手术疗效的多因素影响, objectType=article, longId=179571, objectId=e90f1e95717a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e90f1e95717a, replyNumber=0, likeNumber=84, createdTime=2019-11-18, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e90f1e95717a, moduleTitle=Clinica Chimica Acta：对晚期上皮性卵巢癌或腹膜癌间隔减容手术疗效的多因素影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e90f1e95717a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653752, encodeId=dfec1653e52bf, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Lancet：周剂量密集化疗对欧洲上皮性卵巢癌患者的疗效研究, objectType=article, longId=184044, objectId=e868184044c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e868184044c1, replyNumber=0, likeNumber=83, createdTime=2020-05-04, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e868184044c1, moduleTitle=Lancet：周剂量密集化疗对欧洲上皮性卵巢癌患者的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e868184044c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653750, encodeId=416e1653e5004, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=2018年欧洲肿瘤内科学会《非上皮性卵巢癌诊断、治疗和随访临床实践指南》解读, objectType=article, longId=144580, objectId=99461445800b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99461445800b, replyNumber=0, likeNumber=65, createdTime=2019-05-23, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99461445800b, moduleTitle=2018年欧洲肿瘤内科学会《非上皮性卵巢癌诊断、治疗和随访临床实践指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99461445800b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653748, encodeId=b68c1653e4889, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=BMJ：新辅助化疗能否显著降低晚期上皮性卵巢癌的3年死亡率？, objectType=article, longId=129781, objectId=0230129e81ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0230129e81ec, replyNumber=0, likeNumber=81, createdTime=2018-09-19, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0230129e81ec, moduleTitle=BMJ：新辅助化疗能否显著降低晚期上皮性卵巢癌的3年死亡率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0230129e81ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653749, encodeId=c0b91653e49b9, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=2018 ESMO临床实践指南：非上皮性卵巢癌的诊断，治疗和随访, objectType=article, longId=136713, objectId=5971136e13a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5971136e13a9, replyNumber=0, likeNumber=79, createdTime=2018-07-01, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5971136e13a9, moduleTitle=2018 ESMO临床实践指南：非上皮性卵巢癌的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5971136e13a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653747, encodeId=9d3e1653e47be, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期, objectType=article, longId=125691, objectId=29e0125691d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0125691d2, replyNumber=0, likeNumber=68, createdTime=2018-07-06, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0125691d2, moduleTitle=BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29e0125691d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653745, encodeId=e7b71653e455a, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Oncotarget：下调PPA1对治疗上皮性卵巢癌具有积极作用, objectType=article, longId=106927, objectId=ffaf10692e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffaf10692e20, replyNumber=0, likeNumber=87, createdTime=2017-11-01, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffaf10692e20, moduleTitle=Oncotarget：下调PPA1对治疗上皮性卵巢癌具有积极作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffaf10692e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653746, encodeId=2c981653e46f0, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Cancer Cell Int：上皮性卵巢癌来源的外泌体为何可恢复内皮细胞的迁移, objectType=article, longId=107871, objectId=b7f710e8718b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7f710e8718b, replyNumber=0, likeNumber=74, createdTime=2018-01-18, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7f710e8718b, moduleTitle=Cancer Cell Int：上皮性卵巢癌来源的外泌体为何可恢复内皮细胞的迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7f710e8718b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653743, encodeId=d0771653e433a, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Obstet Gynecol：I期上皮性卵巢癌患者接受保留生育功能手术后的全因死亡率分析！, objectType=article, longId=103161, objectId=079b1031617f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=079b1031617f, replyNumber=0, likeNumber=82, createdTime=2018-02-06, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=079b1031617f, moduleTitle=Obstet Gynecol：I期上皮性卵巢癌患者接受保留生育功能手术后的全因死亡率分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=079b1031617f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1653744, encodeId=a04f1653e44c9, content=<a href='/topic/show?id=f26f20021f8' target=_blank style='color:#2F92EE;'>#上皮性卵巢癌#</a>, objectTitle=Oncogene：上皮性卵巢癌腹腔转移机制, objectType=article, longId=103766, objectId=fb82103e6692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb82103e6692, replyNumber=0, likeNumber=75, createdTime=2018-02-07, rootId=0, userName=hywen7334, userId=8abd24353137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb82103e6692, moduleTitle=Oncogene：上皮性卵巢癌腹腔转移机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb82103e6692)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

上皮性卵巢癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#上皮性卵巢癌# #分子特征# #组织学亚型#

吴琪俊/宁尚伟团队《自然·通讯》：基于蛋白质组学特征解析上皮性卵巢癌不同组织学亚型的分子特征和治疗靶点

2023-12-06发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

全文收起 #激素替代治疗#（menopausal hormone therapy，MHT）是缓解绝经后患者#更年期#症状的有效疗法，妇科恶性肿瘤术后患者使用MHT的安全性和有效性是临床上持续关注的重点问题。早期#子宫内膜癌#（endometrial cancer，EC）术后行MHT不增加复发风险，且有利于提高生活质量。#上皮性卵巢癌#（ovarian cancer，OC）患者术后MHT对无病生存期和总生存期无不利影响，但不建议用于#卵巢性索间质肿瘤#等#非上皮性卵巢肿瘤#。但是激素替换治疗的风险仍然不容忽视，尤其是早筛不严格的前提下。

【综述】| 妇科恶性肿瘤术后激素替代治疗的研究进展

2023-07-20发表于加利福尼亚

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

上皮性卵巢癌PARP抑制剂相关生物标志物有哪些？重点归纳！

2022-01-16

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

伊立替康联合奈达铂治疗复发耐药晚期上皮性卵巢癌的疗效研究

2021-12-30

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌

2021-09-07

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Ann Oncol: MIRV对比研究者选择的化疗在铂耐药上皮性卵巢癌(EOC)患者中的疗效和安全性: III期研究FORWARD I的初次分析结果

2022-05-09

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理

2021-06-13

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

上皮性卵巢癌腹膜后淋巴结复发：预后因素和治疗结局

2021-09-16

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理

2021-07-01

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

有此一说：不成功妊娠，或可降低浸润性上皮性卵巢癌风险

2021-08-14

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Clinica Chimica Acta：对晚期上皮性卵巢癌或腹膜癌间隔减容手术疗效的多因素影响

2019-11-18

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Lancet：周剂量密集化疗对欧洲上皮性卵巢癌患者的疗效研究

2020-05-04

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

2018年欧洲肿瘤内科学会《非上皮性卵巢癌诊断、治疗和随访临床实践指南》解读

2019-05-23

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

BMJ：新辅助化疗能否显著降低晚期上皮性卵巢癌的3年死亡率？

2018-09-19

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

2018 ESMO临床实践指南：非上皮性卵巢癌的诊断，治疗和随访

2018-07-01

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期

2018-07-06

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Oncotarget：下调PPA1对治疗上皮性卵巢癌具有积极作用

2017-11-01

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Cancer Cell Int：上皮性卵巢癌来源的外泌体为何可恢复内皮细胞的迁移

2018-01-18

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Obstet Gynecol：I期上皮性卵巢癌患者接受保留生育功能手术后的全因死亡率分析！

2018-02-06

hywen7334 (审核中...)

前往app查看评论内容

#上皮性卵巢癌#

Oncogene：上皮性卵巢癌腹腔转移机制

2018-02-07

科室
- - 订阅+
  - 更多科室
工具
服务